Pd-1 Blockade In Locally Advanced Rectal Cancer | Nejm

Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient LARC

Journal Club - Locally advanced rectal cancer highly sensitive to single-agent PD-1 blockade

Medical Dialogues

A Phase II trial: dostarlimab alone for the treatment of dMMR locally advanced rectal cancer

PROSPECT: neoadjuvant CRT vs FOLFOX in locally advanced rectal cancer

Locally Advanced Rectal Cancer: PROSPECT Trial

Opting for watch and wait: non-operative strategy for locally advanced rectal cancer with CR

Colorectal Cancer Study with This Amazing Drug

Drbeen Medical Lectures

Dr. Cercek on Induction Chemotherapy in Mismatch Repair Deficient Rectal Cancer

Rectal cancer & total neoadjuvant therapy - RAPIDO trial, POLISH 2 and OPRA trial, PRODIGE 23 trial

Edusurg Clinics

Total neoadjuvant therapy + pembrolizumab in locally-advanced rectal cancer

Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer

Watch and wait vs. surgery: shared decision-making in locally advanced rectal cancer treatment

Locally advanced rectal cancer & total neoadjuvant therapy - Induction vs consolidation chemotherapy

Edusurg Clinics

S1 Episode 1: When Should You Consider Immunotherapy in Colorectal Cancer?

Advances and challenges in the surgical treatment of locally advanced rectal cancer

Dr Pankaj Goyal PD 1 blockade as curative intent therapy in mismatch repair deficient locally adva..

CRSF - Cancer Research and Statistic Foundation

Total Neoadjuvant Therapy in Rectal Cancer in the Community Setting | 2022 Evolution Conference

Total Health | Oncology

Total Neoadjuvant Therapy (TNT) in the management of locally advanced Rectal Cancer

Locally Advanced Rectal Cancer Treatment

Rectal Cancer and Neoadjuvant Chemoradiation - What's the Evidence?? | BTK/RAS-ACS Journal Club #10

Behind The Knife: The Surgery Podcast